4th Quarter - Report
SOCIETY FOR MATERNAL-FETAL MEDICINE for SOCIETY FOR MATERNAL-FETAL MEDICINE
Income
—
Expenses
$10,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Increases in funding in FY 2025 for maternal and infant health programs at NIH, HRSA, AHRQ, FDA, and CDC.
| Lobbyist | Covered position, as disclosed |
|---|---|
| REBECCA ABBOTT New | — |
Health Issues HCR
maternal health legislation, including the Advancing Safe Medications for Moms and Babies Act (HR 1117)
| Lobbyist | Covered position, as disclosed |
|---|---|
| REBECCA ABBOTT New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.